The article 🌱 Patch AM: What investigators revealed in Troy’s deadly hyperbaric chamber hearing appeared first on Troy Patch ...

It's too soon to know if the trend will last. But health providers fear the national discourse around vaccines could yield more sickness and death this winter.

A number of diseases tend to peak in the winter, thanks to indoor gatherings that help germs spread. The list includes not ...

U.S. regulators launch new review of infant RSV therapies from Merck, Sanofi, and AstraZeneca amid scrutiny by Health Secretary Robert F. Kennedy Jr.

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

Learn about the FDA's review of the safety of RSV prevention drugs Clesrovimab and Nirsevimab for infants and toddlers. Find ...

Key Takeaways The U.S. Food and Drug Administration is reviewing two RSV drugs for infantsNo safety issues have been ...

Merck MRK continues to face challenges with Gardasil, its second-largest product, which is a vaccine approved for the prevention of certain cancers caused by human papillomavirus. Though the vaccine’s ...

There are four infections that experts expect to start increasing during winter: colds, influenza, COVID-19 and Respiratory Syncytial Virus, or RSV. All four fall under what are called influenza-like ...

Guidelines recommend a single dose of RSV vaccine for older adults, but long-term data on the duration of protection is limited. In this study of U.S. veterans, effectiveness slid from over 80% in the ...

Researchers found differences in how respiratory syncytial virus spreads among children in rural versus urban communities and concluded that year-round immunizations would minimize risks of large ...